These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6893754)

  • 1. Does basic aluminum sucrose sulfate affect blood coagulability?
    Mcgraw BF; Hesterlee EJ; Gitomer SL; Hollander DH
    Res Commun Chem Pathol Pharmacol; 1980 Nov; 30(2):373-6. PubMed ID: 6893754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective binding of sucralfate to ulcer lesion. II. Experiments in rats with gastric ulcer receiving 14C-sucralfate or potassium 14C-sucrose sulfate.
    Nagashima R; Hinohara Y; Hirano T; Tohira Y; Kamiyama H
    Arzneimittelforschung; 1980; 30(1):84-8. PubMed ID: 6892777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective binding of sucralfate to ulcer lesion. III. Experiments in rats with duodenal ulcer receiving 14C-sucralfate.
    Nagashima R; Hinohara Y; Hirano T
    Arzneimittelforschung; 1980; 30(1):88-91. PubMed ID: 6892778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter, double-blind trial of sucralfate and placebo in duodenal ulcer.
    McHardy GG
    J Clin Gastroenterol; 1981; 3(Suppl 2):147-52. PubMed ID: 7033351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sucralfate, a basic aluminum salt of sucrose sulfate. IV. Interaction with enzyme pepsin.
    Yoshida N; Terao N; Nagashima R
    Arzneimittelforschung; 1980; 30(1):78-80. PubMed ID: 6768370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sucralfate: a review of drug tolerance and safety.
    Fisher RS
    J Clin Gastroenterol; 1981; 3(Suppl 2):181-4. PubMed ID: 7033354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sucralfate, a basic aluminum salt of sucrose sulfate. I. Behaviors in gastroduodenal pH.
    Nagashima R; Yoshida N
    Arzneimittelforschung; 1979; 29(11):1668-76. PubMed ID: 44471
    [No Abstract]   [Full Text] [Related]  

  • 8. Development and characteristics of sucralfate.
    Nagashima R
    J Clin Gastroenterol; 1981; 3(Suppl 2):103-10. PubMed ID: 6798099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective binding of sucralfate to gastric ulcer in man.
    Nakazawa S; Nagashima R; Samloff IM
    Dig Dis Sci; 1981 Apr; 26(4):297-300. PubMed ID: 6894571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and In vivo evaluations of a tableted antacid and sucralfate, a new antiulcer agent.
    McGraw BF; Hesterlee EJ; Lanza FL; Tesler MA
    Am J Gastroenterol; 1981 Nov; 76(5):412-5. PubMed ID: 6895973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sucralfate, a basic aluminum salt of sucrose sulfate. II. Inhibition of peptic hydrolysis as it results from sucrose sulfate interaction with protein substrate, serum albumins.
    Nagashima R; Yoshida N; Terao N
    Arzneimittelforschung; 1980; 30(1):73-6. PubMed ID: 6892774
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the healing capacities of sucralfate and cimetidine in the short-term treatment of duodenal ulcer: a double-blind randomized trial.
    Martin F; Farley A; Gagnon M; Bensemana D
    Gastroenterology; 1982 Mar; 82(3):401-5. PubMed ID: 6895626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of food and antacid on binding of sucralfate to normal and ulcerated gastric and duodenal mucosa in rats.
    Giesing DH; Bighley LD; Iles RL
    J Clin Gastroenterol; 1981; 3(Suppl 2):111-6. PubMed ID: 6895642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sucralfate, a basic aluminum salt of sucrose sulfate. III. Inhibition of peptic hydrolysis of fibrinogen by sucrose sulfate.
    Terao N; Yoshida N; Nagashima R
    Arzneimittelforschung; 1980; 30(1):76-8. PubMed ID: 6892775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fucosylated chondroitin sulfate as a new oral antithrombotic agent.
    Fonseca RJ; Mourão PA
    Thromb Haemost; 2006 Dec; 96(6):822-9. PubMed ID: 17139379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple therapy with sucralfate is not effective in eradicating Helicobacter pylori and does not reduce duodenal ulcer relapse rates.
    Pedrazzoli J; Magalhães AF; Ferraz JG; Trevisan M; De Nucci G
    Am J Gastroenterol; 1994 Sep; 89(9):1501-4. PubMed ID: 8079927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sucralfate: development of a new concept of anti-ulcer treatment. Review of its pharmacodynamic properties].
    Gorget C
    Rev Med Interne; 1985 Jun; 6(3):313-9. PubMed ID: 3901171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic evaluation of the effect of sucralfate therapy and other clinical parameters on the recurrence rate of gastric ulcers.
    Miyake T; Ariyoshi J; Suzaki T; Oishi M; Sakai M; Ueda S
    Dig Dis Sci; 1980 Jan; 25(1):1-7. PubMed ID: 6986240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies of various saccharide sulfate esters as therapeutic agents for peptic ulcer. 2. Synthesis of an aluminum complex of starch hydrolysate sulfate ester and its antipeptic, antiulcerogenic and anticoagulant properties].
    Sugiura M; Kitamikado T; Yamamoto H; Miyake J
    Nihon Yakurigaku Zasshi; 1973 Sep; 69(5):695-700. PubMed ID: 4587297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.